Clinical Trials

582 enrolled

Phase NA Not yet recruiting

Rectal Neoplasms

NCT07432802 2026-02-27

STRADOS

182 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02125786 2026-02-24

A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma

68 enrolled 11 charts

Ependymoma

NCT06918132 2026-02-24

N-PLANC

60 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01946529 2026-02-23

Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors

Phase 3 Not yet recruiting

24 enrolled 11 charts

Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

NCT06448286 2026-02-19

PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma

60 enrolled

CNS

Glioblastoma

NCT07384884 2026-02-19

SLITT-GBM

Phase NA Not yet recruiting

12 enrolled

CNS

Brain Neoplasms

NCT06528691 2026-02-17

Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors

Phase EARLY_PHASE1 Recruiting

52 enrolled

CNS

Glioma, Central Nervous System Neoplasms

NCT07144384 2026-02-13

Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma

40 enrolled

Dermatologic

Carcinoma, Basal Cell

NCT05451290 2026-02-12

Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer

30 enrolled

Advanced Biliary Tract Carcinoma

NCT06135714 2026-02-11

OLIGAMI

340 enrolled

Phase 3 Not yet recruiting

Breast Neoplasms

NCT07402538 2026-02-11

Surgery With or Without Neoadjuvant Treatment of SBRT Plus Chemoimmunotherapy in Resectable Locally Advanced Oral and HPV-unrelated Oropharyngeal Squamous Cell Carcinoma

184 enrolled

Phase NA Not yet recruiting

Mouth Neoplasms, Oropharyngeal Neoplasms

NCT07383142 2026-02-06

Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence (CHOICE-2)

202 enrolled

Thymic epithelial tumor

NCT07301268 2026-02-03

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

Phase 2 Suspended

36 enrolled

CNSSarcoma

Astrocytoma, Glioblastoma, Gliosarcoma

NCT05894083 2026-02-02

A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)

150 enrolled

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms

NCT02926911 2026-01-27

COMET

997 enrolled 16 charts

Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Ductal

NCT06810609 2026-01-27

InDuRanS

176 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06997094 2026-01-26

Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer

Phase 1 Recruiting

24 enrolled

Human Papillomavirus-Negative Neck Squamous Cell Carcinoma

NCT04821843 2026-01-21

Neoadjuvant Treatment Modalities in Esophageal Cancer

2,000 enrolled

Esophageal Neoplasms

NCT06468280 2026-01-21

ROSETTE

84 enrolled

Stomach Neoplasms

NCT05826509 2026-01-15

SUGAR

240 enrolled

Genitourinary

Prostatic Neoplasms

NCT06660810 2026-01-15

Neoadjuvant Intralesional Injection of Talimogene Laherparepvec

2 enrolled

Sarcoma

NCT07339488 2026-01-14

ILDR-03

43 enrolled

Esophageal Squamous Cell Carcinoma

NCT05735912 2026-01-13

ERASIN-RCT

60 enrolled

Endocrine

Insulinoma

NCT05717166 2025-12-31

SABR-SYNC

Phase 2 Enrolling by invitation

180 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT07139951 2025-12-31

Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for the Treatment of Patients With Gastric and Gastroesophageal Junction Adenocarcinoma at High Risk of Peritoneal Recurrence

16 enrolled

Clinical Stage I Gastric Cancer AJCC v8

NCT06835049 2025-12-30

TNT-HYPE

24 enrolled

Sarcoma

Hyperthermia, Sarcoma

NCT07073365 2025-12-30

BOOST

70 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05278741 2025-12-26

BREAST

32 enrolled

Breast Neoplasms

NCT03042169 2025-12-23

SURGIGAST

Phase 3 Terminated

6 enrolled

Stomach Neoplasms

NCT04587739 2025-12-23

KARCHER-1

Phase 1 Recruiting

30 enrolled

Carcinoma, Hepatocellular

NCT07248956 2025-12-23

Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma

116 enrolled

Hypopharyngeal Neoplasms

NCT01005745 2025-12-19

Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic Melanoma

Phase NA Completed

19 enrolled 7 charts

Dermatologic

Melanoma

NCT00929214 2025-12-17

Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients

35 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT01871766 2025-12-17

Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

115 enrolled

Sarcoma

Rhabdomyosarcoma

NCT03534947 2025-12-16

SONIB

Phase 2 Completed

16 enrolled

Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms

NCT01723774 2025-12-09

PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer

84 enrolled 17 charts

Breast Neoplasms

NCT07272356 2025-12-09

Evaluation of Efficacy of Minimally Invasive Local Therapy for Lung Tumors and Its Impact on Breathing Function

68 enrolled

Carcinoma, Non-Small-Cell Lung, Respiratory Aspiration

NCT07264647 2025-12-04

Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC)

30 enrolled